Jupiter Investment Management’s Charles River Laboratories CRL Stock Holding History

Jupiter Investment Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-60,315	Closed	-$5.03M	–	378
2016 Q3	$5.03M	Buy	60,315 +2,074	+4%	+$174K	0.09%	156
2016 Q2	$4.8M	Buy	58,241 +27,426	+89%	+$2.26M	0.09%	181
2016 Q1	$2.34M	Buy	+30,815	New	+$2.28M	0.05%	230
2014 Q4	–	Sell	-12,817	Closed	-$765K	–	349
2014 Q3	$765K	Sell	12,817 -60,170	-82%	-$3.44M	0.04%	248
2014 Q2	$3.91M	Buy	+72,987	New	+$4.01M	0.22%	114

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Jupiter Investment Management's CRL Position: Q4 2016 in Review

Jupiter Investment Management sold out of Charles River Laboratories (CRL) in Q4 2016, closing a stake of 60,315 shares — an estimated $5.03M sold.

Jupiter Investment Management first reported a position in CRL in Q2 2014 and held it in 5 quarters. The position peaked at $5.03M in Q3 2016. 297 funds tracked by Wall St. Rank hold CRL as of Q4 2016.

Jupiter Investment Management reported no remaining Charles River Laboratories position as of Q4 2016 after selling out during the quarter.
Jupiter Investment Management sold 60,315 Charles River Laboratories shares in Q4 2016, an estimated $5.03M.
Jupiter Investment Management first reported a position in Charles River Laboratories in Q2 2014 and held it in 5 quarters.
Jupiter Investment Management's Charles River Laboratories position peaked at $5.03M in Q3 2016.
297 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2016.

Based on Jupiter Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.